|
|
||||||||
Ann Thorac Surg 2002;74:899-905
© 2002 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, University of Washington, Seattle, WA, USA
* Address reprint requests to Dr Mulligan, Division of Cardiothoracic Surgery, Box 356310, 1959 NE Pacific St, University of Washington, Seattle, WA 09195 USA
e-mail: msmdu{at}uwashington.edu
Presented at the Thirty-eighth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, January 2830, 2002.
Background. We have recently demonstrated a role for selected chemokines in a rat model of lung ischemia reperfusion injury (LIRI). We have further shown that pretreatment with cyclosporine A (CSA) is protective. The precise cellular events regulating this model are unknown. The alveolar macrophage (AM) is a key effector cell in multiple models of acute lung injury, and it likely plays a central role in LIRI as well. The present studies were undertaken to determine whether CSA functions in part by modifying the chemokine response of AMs to hypoxia and reoxygenation in vitro.
Methods. Alveola macrophages were rendered hypoxic (0.5%) for 2 hours and reoxygenated for 6 hours. The secreted chemokine content in the media was quantified by enzyme-linked immunosorbent assay, and nuclear protein was analyzed after electro-mobility shift assay. When employed, CSA was administered 30 minutes before hypoxia.
Results. Alveolar macrophages demonstrated a marked increase in the secretion of the chemokines, MIP-2, MIP-1
, CINC, and MCP-1, in response to hypoxia and reoxygenation. This increase was dependent on mRNA transcription and de novo protein synthesis. It was also blocked by a specific inhibitor of the nuclear translocation factor, NF-
B. Pretreatment with CSA (500 ng/mL) significantly reduced expression of chemokines and activation of NF-
B.
Conclusions. Cyclosporine A attenuates the chemokine response of AMs in vitro to hypoxia and reoxygenation at the pretranscriptional level through modulation of NF-
B. These findings suggest the potential mechanism of action of CSAs protective effects in lung ischemia reperfusion injury.
This article has been cited by other articles:
![]() |
A. Emaminia, D. J. LaPar, Y. Zhao, J. F. Steidle, D. A. Harris, V. E. Laubach, J. Linden, I. L. Kron, and C. L. Lau Adenosine A2A Agonist Improves Lung Function During Ex Vivo Lung Perfusion Ann. Thorac. Surg., November 1, 2011; 92(5): 1840 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chao, P. Donham, N. van Rooijen, J. G. Wood, and N. C. Gonzalez Monocyte Chemoattractant Protein-1 Released from Alveolar Macrophages Mediates the Systemic Inflammation of Acute Alveolar Hypoxia , July 1, 2011; 45(1): 53 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. den Hengst, J. F. Gielis, J. Y. Lin, P. E. Van Schil, L. J. De Windt, and A. L. Moens Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process Am J Physiol Heart Circ Physiol, November 1, 2010; 299(5): H1283 - H1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. McCourtie, H. E. Merry, P. S. Wolf, E. FitzSullivan, J. C. Keech, A. S. Farivar, and M. S. Mulligan Synergistic Protection in Lung Ischemia-Reperfusion Injury With Calcineurin and Thrombin Inhibition Ann. Thorac. Surg., June 1, 2010; 89(6): 1766 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamada, Y. Sekine, S. Yoshida, K. Yasufuku, I. Petrache, H. L. Benson, D. D. Brand, I. Yoshino, and D. S. Wilkes Type V Collagen-Induced Oral Tolerance Plus Low-Dose Cyclosporine Prevents Rejection of MHC Class I and II Incompatible Lung Allografts J. Immunol., July 1, 2009; 183(1): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. McCourtie, A. S. Farivar, S. M. Woolley, H. E. Merry, P. S. Wolf, B. Mackinnon-Patterson, J. C. Keech, E. FitzSullivan, and M. S. Mulligan Alveolar Macrophage Secretory Products Effect Type 2 Pneumocytes Undergoing Hypoxia-Reoxygenation Ann. Thorac. Surg., December 1, 2008; 86(6): 1774 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Wolf, H. E. Merry, A. S. Farivar, A. S. McCourtie, and M. S. Mulligan Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 656 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. McCourtie, H. E. Merry, A. S. Farivar, C. H. Goss, and M. S. Mulligan Alveolar Macrophage Secretory Products Augment the Response of Rat Pulmonary Artery Endothelial Cells to Hypoxia and Reoxygenation Ann. Thorac. Surg., March 1, 2008; 85(3): 1056 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhao, L. G. Fernandez, A. Doctor, A. K. Sharma, A. Zarbock, C. G. Tribble, I. L. Kron, and V. E. Laubach Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1018 - L1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Farivar, H. E. Merry, M. J. Fica-Delgado, A. S. McCourtie, B. C. Mackinnon-Patterson, and M. S. Mulligan Interleukin-6 Regulation of Direct Lung Ischemia Reperfusion Injury Ann. Thorac. Surg., August 1, 2006; 82(2): 472 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Farivar, B. C. Mackinnon-Patterson, A. D. Barnes, A. S. McCourtie, and M. S. Mulligan Cyclosporine Modulates the Response to Hypoxia-Reoxygenation in Pulmonary Artery Endothelial Cells Ann. Thorac. Surg., March 1, 2005; 79(3): 1010 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Naidu, S. M. Woolley, A. S. Farivar, R. Thomas, C. H. Fraga, C. H. Goss, and M. S. Mulligan Early tumor necrosis factor-{alpha} release from the pulmonary macrophage in lung ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1502 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Woolley, A. S. Farivar, B. V. Naidu, M. Rosengart, R. Thomas, C. Fraga, and M. S. Mulligan Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 376 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Naidu, B. Krishnadasan, A. S. Farivar, S. M. Woolley, R. Thomas, N. Van Rooijen, E. D. Verrier, and M. S. Mulligan Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 200 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury , February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |